| Name | 2-Hydroxy-3-nitrobiphenyl-3-carboxylic acid |
|---|---|
| Synonyms |
[1,1'-Biphenyl]-3-cboxylic acid, 2'-hydroxy-3'-nitro
3’-Nitro-2’-hydroxy[1,1’]-biphenyl-3-cboxylic Acid 2'- hydroxy -3'- nitrobiphenyl -3- cboxylic acid [1,1'-Biphenyl]-3-carboxylic acid,2'-hydroxy-3'-nitro Eltrombopag Impurity 44 Eltrombopag Impurity 21 Eltrombopag Impurity 13 4,5,9,16-Pyrenetetrone Eltrombopag olamine Intermediate 2 3-(2-hydroxy-3-nitrophenyl)benzoic acid 3-(2-hydroxy-3-nitrophenyl)benzoicaci 2'-hydroxy-3'-nitro-3-biphenylcboxylic acid 2'-Hydroxy-3'-nitrobiphenyl-3-carboxylic acid 2'-Hydroxy-3'-nitro-3-biphenylcarboxylic acid 2'-Hydroxy-3'-nitro-[1,1'-biphenyl]-3-cboxylic acid Eltrombopag o 2'-hydroxy-3'-nitro-3- biphenylcboxylic acid 2-HYDROXY-3''-NITRO-BIPHENYL-3-CBOXYLIC ACID Nalbuphine Impurity 11 |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 452.2±40.0 °C at 760 mmHg |
| Molecular Formula | C13H9NO5 |
| Molecular Weight | 259.214 |
| Flash Point | 193.8±15.8 °C |
| Exact Mass | 259.048065 |
| PSA | 103.35000 |
| LogP | 2.83 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.669 |
|
~%
376591-95-6 |
| Literature: LIGAND PHARMACEUTICALS, INC. Patent: WO2006/47344 A1, 2006 ; Location in patent: Page/Page column 45; 155 ; |
|
~76%
376591-95-6 |
| Literature: Erickson-Miller, Connie J; Eppley, Daniel F.; Jenkins, Julian; Luengo, Juan I.; Liu, Nannan; Price, Alan T.; Shaw, Anthony N.; Visonneau, Sophie; Wiggall, Kenneth Patent: US2004/19190 A1, 2004 ; Location in patent: Page 18 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |